Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0181


Gastric cancer recurrence and laparoscopic gastrectomy.

Hans-Joachim Meyer, MD.

Affiliation: Prof. Hans-Joachim Meyer, Department of General and Visceral Surgery, Städtisches Klinikum Solingen, Gotenstrasse 1, 42653 Solingen, Germany.

Tel: +49-212-5472401; FAX: +49-212-5472682,


Since there is no abstract available we provide the first paragraph

Recurrence is the cause of treatment failure that leads to death cancer patients. The ultimate goal of current and future biomedical research is how to understand and develop effective drugs to overcome molecular mechanisms underlying cancer recurrence [1, 2]. Despite complete tumor resection (R0) and adjuvant chemotherapy, radiotherapy and targeted therapy, recurrence rates in patients with stages II/III solid cancer still remain high suggesting that cancer is a highly complex, heterogeneous and incurable disease [3]. Evidence suggests that laparoscopic surgery improves postoperative short-term outcomes and quality-of-life (QOL) without any negative effect on oncological outcomes of patients with colon cancer but the impact of this minimally invasive approach on recurrence risk for gastric, rectal and other solid cancer is still unclear [4-10].

(Citation: Gastric & Breast Cancer 2011; 10(3): 173-175)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 29 June 2011